PMID- 29202472 OWN - NLM STAT- MEDLINE DCOM- 20190507 LR - 20190507 IS - 1558-8238 (Electronic) IS - 0021-9738 (Print) IS - 0021-9738 (Linking) VI - 128 IP - 1 DP - 2018 Jan 2 TI - Hyposialylated IgG activates endothelial IgG receptor FcgammaRIIB to promote obesity-induced insulin resistance. PG - 309-322 LID - 89333 [pii] LID - 10.1172/JCI89333 [doi] AB - Type 2 diabetes mellitus (T2DM) is a common complication of obesity. Here, we have shown that activation of the IgG receptor FcgammaRIIB in endothelium by hyposialylated IgG plays an important role in obesity-induced insulin resistance. Despite becoming obese on a high-fat diet (HFD), mice lacking FcgammaRIIB globally or selectively in endothelium were protected from insulin resistance as a result of the preservation of insulin delivery to skeletal muscle and resulting maintenance of muscle glucose disposal. IgG transfer in IgG-deficient mice implicated IgG as the pathogenetic ligand for endothelial FcgammaRIIB in obesity-induced insulin resistance. Moreover, IgG transferred from patients with T2DM but not from metabolically healthy subjects caused insulin resistance in IgG-deficient mice via FcgammaRIIB, indicating that similar processes may be operative in T2DM in humans. Mechanistically, the activation of FcgammaRIIB by IgG from obese mice impaired endothelial cell insulin transcytosis in culture and in vivo. These effects were attributed to hyposialylation of the Fc glycan, and IgG from T2DM patients was also hyposialylated. In HFD-fed mice, supplementation with the sialic acid precursor N-acetyl-D-mannosamine restored IgG sialylation and preserved insulin sensitivity without affecting weight gain. Thus, IgG sialylation and endothelial FcgammaRIIB may represent promising therapeutic targets to sever the link between obesity and T2DM. FAU - Tanigaki, Keiji AU - Tanigaki K AD - Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Sacharidou, Anastasia AU - Sacharidou A AD - Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Peng, Jun AU - Peng J AD - Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Chambliss, Ken L AU - Chambliss KL AD - Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Yuhanna, Ivan S AU - Yuhanna IS AD - Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Ghosh, Debabrata AU - Ghosh D AD - Department of Bioengineering, University of Texas at Dallas, Richardson Texas, USA. AD - Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Ahmed, Mohamed AU - Ahmed M AD - Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Szalai, Alexander J AU - Szalai AJ AD - Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. FAU - Vongpatanasin, Wanpen AU - Vongpatanasin W AD - Hypertension Section, Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Mattrey, Robert F AU - Mattrey RF AD - Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Chen, Qiushi AU - Chen Q AD - The Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA. FAU - Azadi, Parastoo AU - Azadi P AD - The Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA. FAU - Lingvay, Ildiko AU - Lingvay I AD - Division of Endocrinology, Diabetes, and Metabolism and Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Botto, Marina AU - Botto M AD - Centre for Complement and Inflammation Research, Division of Immunology and Inflammation, Department of Medicine, Imperial College London, London, United Kingdom. FAU - Holland, William L AU - Holland WL AD - Touchstone Diabetes Center, Department of Internal Medicine, and. FAU - Kohler, Jennifer J AU - Kohler JJ AD - Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Sirsi, Shashank R AU - Sirsi SR AD - Department of Bioengineering, University of Texas at Dallas, Richardson Texas, USA. AD - Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Hoyt, Kenneth AU - Hoyt K AD - Department of Bioengineering, University of Texas at Dallas, Richardson Texas, USA. AD - Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Shaul, Philip W AU - Shaul PW AD - Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. FAU - Mineo, Chieko AU - Mineo C AD - Center for Pulmonary and Vascular Biology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. LA - eng GR - R01 DK099092/DK/NIDDK NIH HHS/United States GR - R01 HL115122/HL/NHLBI NIH HHS/United States GR - K25 EB017222/EB/NIBIB NIH HHS/United States GR - R01 DK108833/DK/NIDDK NIH HHS/United States GR - R01 GM090271/GM/NIGMS NIH HHS/United States GR - R01 DK110127/DK/NIDDK NIH HHS/United States GR - P41 GM103490/GM/NIGMS NIH HHS/United States GR - T32 HL098040/HL/NHLBI NIH HHS/United States GR - R21 CA212851/CA/NCI NIH HHS/United States GR - S10 OD018530/OD/NIH HHS/United States GR - K23 RR024470/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20171127 PL - United States TA - J Clin Invest JT - The Journal of clinical investigation JID - 7802877 RN - 0 (Fcgr2b protein, mouse) RN - 0 (Hexosamines) RN - 0 (Immunoglobulin G) RN - 0 (Receptors, IgG) RN - X80PR7P73R (N-acetylmannosamine) SB - IM MH - Animals MH - Diabetes Mellitus, Type 2/genetics/*metabolism/pathology MH - Endothelial Cells/metabolism/pathology MH - Hexosamines/pharmacology MH - Immunoglobulin G/genetics/*metabolism MH - *Insulin Resistance MH - Mice MH - Mice, Knockout MH - Obesity/genetics/*metabolism/pathology MH - Receptors, IgG/genetics/*metabolism MH - Transcytosis/drug effects PMC - PMC5749535 OTO - NOTNLM OT - Metabolism OT - Mouse models OT - Obesity OT - Vascular Biology OT - endothelial cells COIS- Conflict of interest: The authors have declared that no conflict of interest exists. EDAT- 2017/12/05 06:00 MHDA- 2019/05/08 06:00 PMCR- 2018/04/02 CRDT- 2017/12/05 06:00 PHST- 2016/06/30 00:00 [received] PHST- 2017/10/17 00:00 [accepted] PHST- 2017/12/05 06:00 [pubmed] PHST- 2019/05/08 06:00 [medline] PHST- 2017/12/05 06:00 [entrez] PHST- 2018/04/02 00:00 [pmc-release] AID - 89333 [pii] AID - 10.1172/JCI89333 [doi] PST - ppublish SO - J Clin Invest. 2018 Jan 2;128(1):309-322. doi: 10.1172/JCI89333. Epub 2017 Nov 27.